Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Other Working Capital Changes: 2012-2025

Historic Other Working Capital Changes for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Sep 2025 value amounting to -$1.6 million.

  • Enanta Pharmaceuticals' Other Working Capital Changes fell 155.06% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $903,000, marking a year-over-year decrease of 81.92%. This contributed to the annual value of $379,000 for FY2025, which is 92.41% down from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Other Working Capital Changes is -$1.6 million, which was down 219.31% from $1.4 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Other Working Capital Changes high stood at $4.5 million for Q4 2022, and its period low was -$9.8 million during Q2 2021.
  • For the 3-year period, Enanta Pharmaceuticals' Other Working Capital Changes averaged around -$378,889, with its median value being -$1.0 million (2023).
  • Data for Enanta Pharmaceuticals' Other Working Capital Changes shows a peak YoY increase of 451.02% (in 2023) and a maximum YoY decrease of 1,981.52% (in 2023) over the last 5 years.
  • Enanta Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$2.7 million in 2021, then skyrocketed by 267.82% to $4.5 million in 2022, then slumped by 122.73% to -$1.0 million in 2023, then soared by 100.02% to $217 in 2024, then slumped by 155.06% to -$1.6 million in 2025.
  • Its Other Working Capital Changes was -$1.6 million in Q3 2025, compared to $1.4 million in Q2 2025 and -$1.8 million in Q1 2025.